Newsroom

Categories: biopharma, Digital Pathology, AI

CellCarta Launches Digital Pathology and AI Consortium to Accelerate Platform-Agnostic Biomarker Innovation Across Drug Development

July 15, 2026

Categories: Omics & Genetics, Biotechnology, Drug Discovery & Development, biopharma

Alithea Genomics Launches Early Access Program for MERCURIUS™ 1536 DRUG-seq, Bringing Transcriptomics to Compound Screening Scale

June 16, 2026

Categories: Corporate, Finance & Investor, Clinical Diagnostics, biopharma

Leica Biosystems and CellCarta expand collaborative companion diagnostic development model to accelerate commercialization globally

June 1, 2026

Categories: Research, Corporate, Finance & Investor, biopharma

GenNext and Agilent unveil groundbreaking technology integration to accelerate high-value decision making in biopharmaceutical research

September 11, 2024

Categories: General Laboratory, biopharma

Synexa Life Sciences expands biomarker discovery capabilities with the addition of Olink® target platform

March 4, 2024

Categories: Biotechnology, Drug Discovery & Development, biopharma

GenNext® Technologies announces partnership with Emery Pharma on full-solution biopharmaceutical protein footprinting services

May 17, 2023

Categories: Analytical Chemistry, biopharma

New application-specific LC system to precisely deliver high-purity products or isolation of contaminants

October 10, 2022

Categories: Pharma, Corporate, Finance & Investor, biopharma

Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities in clinical drug development.

May 19, 2022

Categories: Drug Discovery & Development, Corporate, Finance & Investor, biopharma

Arctoris and Evariste Technologies form a joint venture to identify novel small molecule cMET inhibitors for non-small cell lung cancer

March 7, 2022